本頁面由Tiger Trade Technology Pte. Ltd.提供服務

奧洛茲美醫療

67.57
+0.26000.39%
成交量:45.86萬
成交額:3,099.26萬
市值:80.05億
市盈率:26.39
高:67.90
開:67.33
低:67.12
收:67.31
52周最高:82.22
52周最低:47.50
股本:1.18億
流通股本:1.16億
量比:0.38
換手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):2.56
每股收益(LYR):2.56
淨資產收益率:153.59%
總資產收益率:22.24%
市淨率:164.00
市盈率(LYR):26.39

資料載入中...

2023/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/28

SEC問詢函

Form CORRESP - Correspondence
2023/06/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/08

重要事件披露

8-K - Current report
2023/04/18

關聯方擬減持公告

144 - Report of proposed sale of securities